Literature DB >> 21255816

Antibody-mediated neutralization of flaviviruses: a reductionist view.

Kimberly A Dowd1, Theodore C Pierson.   

Abstract

Flaviviruses are a group of ~70 small RNA viruses responsible for significant morbidity and mortality across the globe. Efforts to develop effective vaccines for several clinically important flaviviruses are underway. Antibodies are a significant component of the host's protective response against flavivirus infection with the potential to contribute to immunity via several distinct mechanisms, including an ability to directly neutralize virus infection. Conversely, virus-reactive antibodies have been implicated in the increased risk of severe clinical manifestations following secondary dengue virus infection. In this review, we will discuss recent progress toward understanding the molecular basis of antibody-mediated neutralization of flaviviruses. Neutralization requires engagement of the virion with a stoichiometry that exceeds a required threshold. From this perspective, we will discuss viral and host factors that impact the number of antibody molecules bound to the virus particle and significantly modulate the potency of neutralizing antibodies.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21255816      PMCID: PMC3100196          DOI: 10.1016/j.virol.2010.12.020

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  118 in total

1.  Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10.

Authors:  Joshua S Klein; Priyanthi N P Gnanapragasam; Rachel P Galimidi; Christopher P Foglesong; Anthony P West; Pamela J Bjorkman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-16       Impact factor: 11.205

Review 2.  Antibody-dependent enhancement of viral infectivity.

Authors:  J S Porterfield
Journal:  Adv Virus Res       Date:  1986       Impact factor: 9.937

3.  Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model.

Authors:  C W Mandl; F Guirakhoo; H Holzmann; F X Heinz; C Kunz
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

4.  Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever.

Authors:  S C Kliks; A Nisalak; W E Brandt; L Wahl; D S Burke
Journal:  Am J Trop Med Hyg       Date:  1989-04       Impact factor: 2.345

5.  Profiles of antibody-dependent enhancement of dengue virus type 2 infection.

Authors:  D M Morens; S B Halstead; N J Marchette
Journal:  Microb Pathog       Date:  1987-10       Impact factor: 3.738

6.  Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants.

Authors:  S C Kliks; S Nimmanitya; A Nisalak; D S Burke
Journal:  Am J Trop Med Hyg       Date:  1988-03       Impact factor: 2.345

7.  A new mechanism for the neutralization of enveloped viruses by antiviral antibody.

Authors:  S W Gollins; J S Porterfield
Journal:  Nature       Date:  1986 May 15-21       Impact factor: 49.962

8.  Failure of a dengue 1 sub-unit vaccine to protect mice against a lethal dengue virus infection.

Authors:  J G Aaskov; L Williams; J Fletcher; R Hay
Journal:  Am J Trop Med Hyg       Date:  1988-11       Impact factor: 2.345

9.  Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens.

Authors:  Wayne D Crill; Holly R Hughes; Mark J Delorey; Gwong-Jen J Chang
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

10.  A therapeutic antibody against west nile virus neutralizes infection by blocking fusion within endosomes.

Authors:  Bruce S Thompson; Bastiaan Moesker; Jolanda M Smit; Jan Wilschut; Michael S Diamond; Daved H Fremont
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

View more
  91 in total

1.  Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature.

Authors:  Michelle C Sabo; Vincent C Luca; Stuart C Ray; Jens Bukh; Daved H Fremont; Michael S Diamond
Journal:  Virology       Date:  2011-11-12       Impact factor: 3.616

2.  Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells.

Authors:  Simona Zompi; Brian H Santich; P Robert Beatty; Eva Harris
Journal:  J Immunol       Date:  2011-11-30       Impact factor: 5.422

Review 3.  Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex.

Authors:  Mario Lobigs; Michael S Diamond
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

4.  Dengue virus: Bumps in the road to therapeutic antibodies.

Authors:  Leslie Goo; Theodore C Pierson
Journal:  Nature       Date:  2015-08-20       Impact factor: 49.962

5.  Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.

Authors:  Alexander J McAuley; Maricela Torres; Jessica A Plante; Claire Y-H Huang; Dennis A Bente; David W C Beasley
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

Review 6.  Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Authors:  Anuja Mathew; Elizabeth Townsley; Francis A Ennis
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

7.  A new class of broadly neutralizing antibodies that target the glycan loop of Zika virus envelope protein.

Authors:  Panke Qu; Chao Zhang; Min Li; Weimin Ma; Pei Xiong; Qingwei Liu; Gang Zou; Dimitri Lavillette; Feifei Yin; Xia Jin; Zhong Huang
Journal:  Cell Discov       Date:  2020-02-04       Impact factor: 10.849

Review 8.  Zika Virus Pathogenesis and Tissue Tropism.

Authors:  Jonathan J Miner; Michael S Diamond
Journal:  Cell Host Microbe       Date:  2017-02-08       Impact factor: 21.023

Review 9.  Zika Virus: Immunity and Vaccine Development.

Authors:  Theodore C Pierson; Barney S Graham
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

10.  Dynamics of Dengue Virus (DENV)-Specific B Cells in the Response to DENV Serotype 1 Infections, Using Flow Cytometry With Labeled Virions.

Authors:  Marcia Woda; Heather Friberg; Jeffrey R Currier; Anon Srikiatkhachorn; Louis R Macareo; Sharone Green; Richard G Jarman; Alan L Rothman; Anuja Mathew
Journal:  J Infect Dis       Date:  2016-07-20       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.